The estimated Net Worth of Ronny B Lancaster is at least $2.74 Milione dollars as of 26 August 2022. Mr. Lancaster owns over 50,000 units of Orasure Technologies stock worth over $445,324 and over the last 21 years he sold OSUR stock worth over $2,112,196. In addition, he makes $184,999 as Independent Director at Orasure Technologies.
Ronny has made over 4 trades of the Orasure Technologies stock since 2011, according to the Form 4 filled with the SEC. Most recently he bought 50,000 units of OSUR stock worth $200,000 on 26 August 2022.
The largest trade he's ever made was selling 102,715 units of Orasure Technologies stock on 20 May 2011 worth over $785,770. On average, Ronny trades about 8,303 units every 133 days since 2004. As of 26 August 2022 he still owns at least 104,782 units of Orasure Technologies stock.
You can see the complete history of Mr. Lancaster stock trades at the bottom of the page.
Ronny B. Lancaster J.D. serves as Independent Director of the Company. Mr. Lancaster served as Senior Vice President, Federal Government Relations of Assurant, Inc., a provider of specialty insurance and insurance-related products and services. Prior to that, Mr. Lancaster served as Chief Operating Officer of the Morehouse School of Medicine, Executive Assistant to the Secretary and Principal Deputy Assistant Secretary for Planning and Evaluation at the U.S. Department of Health and Human Services, General Counsel of Hamilton Enterprises, Inc., Senior Washington Representative for Blue Cross/Blue Shield Association, and Chief of the Division of Fee-For-Service Plans at the U.S. Office of Personnel Management. Mr. Lancaster received a B.A. in Economics from the Catholic University of America, an M.B.A. from the Wharton School of the University of Pennsylvania, and a J.D. from The Georgetown University Law Center. He is admitted to the Bars of Pennsylvania and the District of Columbia. Mr. Lancaster previously served on the board of directors of Immucor, Inc.
As the Independent Director of Orasure Technologies, the total compensation of Ronny Lancaster at Orasure Technologies is $184,999. There are 8 executives at Orasure Technologies getting paid more, with Stephen Tang having the highest compensation of $2,114,820.
Ronny Lancaster is 68, he's been the Independent Director of Orasure Technologies since 2003. There are no older and 18 younger executives at Orasure Technologies.
Ronny's mailing address filed with the SEC is 220 EAST FIRST STREET, , BETHLEHEM, PA, 18015.
Over the last 21 years, insiders at Orasure Technologies have traded over $21,897,384 worth of Orasure Technologies stock and bought 196,200 units worth $1,037,188 . The most active insiders traders include Douglas A Michels, Ronald H Spair e Michael J Gausling. On average, Orasure Technologies executives and independent directors trade stock every 43 days with the average trade being worth of $221,123. The most recent stock trade was executed by Kathleen Gallagher Weber on 19 December 2023, trading 24,129 units of OSUR stock currently worth $194,238.
based in bethlehem, pennsylvania, orasure technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. these products include tests for the detection of antibodies to the hiv virus, including the oraquick® in-home hiv test, oraquick advance® rapid hiv-1/2 antibody test and the orasure® hiv-1 oral specimen collection device, a test for antibodies to the hcv virus, the oraquick® hcv rapid antibody test, and oral fluid testing solutions for drugs of abuse testing, including intercept® oral fluid drug testing system and q.e.d.® saliva alcohol test. orasure also manufactures and sells several leading cryosurgical products. these include: histofreezer®, a product for the cryosurgical removal of common and plantar warts and several other benign skin lesions, sold to the professional or physician office market, as well as an over-the-counter product fo
Orasure Technologies executives and other stock owners filed with the SEC include: